Startup Funding Options: From Bootstrapping to Series A in 2026...
The Academy of Motion Picture Arts and Sciences dropped a bombshell on Friday that will reshape Hollywood's relationship with generative AI. For the 9...
Building your first SaaS is like assembling IKEA furniture without the manual. You know each piece does something, but the order matters more than yo...
SoftBank Just Created a Robotics Company That Builds Data Centers — and It's Already Eyeing a $100B IPO...
For the first time ever, all four hyperscalers — Alphabet, Amazon, Meta, and Microsoft — reported earnings on the same day. And the headline numbe...
Socure raised $156M at a $5.2B valuation and bought agentic-AI startup Fravity to fight machine-speed fraud with AI agents of its own.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Bending Spoons is buying Airtable for $1.285 billion in all cash — about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.
The FDA cleared Revolution Medicines' daraxonrasib, the first broad RAS-targeted pill for metastatic pancreatic cancer, doubling median survival to 13.2 months at a $477,000-a-year list price.
The FDA cleared GENGLYCOS, Ultragenyx's first gene therapy: a one-time $2.7 million infusion targeting the root cause of glycogen storage disease type Ia.
AusperBio raised $120M to push AHB-137, an antisense drug that cleared hepatitis B in 68% of a small trial, toward the first functional cure for a disease 240 million people live with.
